NCT02533128View on ClinicalTrials.gov

Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

458

Participants

Timeline

Start Date

October 14, 2015

Primary Completion Date

May 17, 2019

Study Completion Date

April 17, 2020

Conditions
HypotensionPostoperative ComplicationsAcute Coronary SyndromeHeart FailureCoronary OcclusionStrokeAcute Kidney InjuryRenal Insufficiency, ChronicDeath
Interventions
DRUG

Liberal blood pressure management

Protocolized hemodynamic management to maintain mean arterial pressure (MAP) \> 60 mmHg

DRUG

Tight blood pressure management

Protocolized hemodynamic management to maintain mean arterial pressure (MAP) \> 75 mmHg

Trial Locations (1)

9007

Kantonsspital St. Gallen, Sankt Gallen

All Listed Sponsors
lead

Miodrag Filipovic, Prof. Dr. med.

OTHER

NCT02533128 - Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery | Biotech Hunter | Biotech Hunter